OncoImmunology
Volume 9, 2020 - Issue 1
Open access
2,375
Views
26
CrossRef citations to date
0
Altmetric
Back Matter
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies
Jacobo Rogadoa Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, Spain;b Medical Oncology Department, HU Infanta Leonor, Madrid, SpainView further author information
, Nuria Romero-Laordena Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, José Miguel Sanchez-Torresa Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, Ana María Ramos-Levic Endocrinology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, Vilma Pacheco-Barciaa Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, Ana Isabel Ballesterosa Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, Reyes Arranzd Hematology Department, HU La Princesa, Madrid, SpainView further author information
, Alicia Lorenzoe Hematology Department, Complejo Asistencial De Segovia, Segovia, Castilla Y León, SpainView further author information
, Pedro Gullonf Social and Cardiovascular Epidemiology Research Group, Alcalá University, Madrid, SpainView further author information
, Ana Garridoa Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, José María Serra López-Matenciog Hospital Pharmacy Department, HU La Princesa, Madrid, SpainView further author information
, Olga Donnaya Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, Magdalena Adradosh Pathology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, Pablo Costasa Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, Javier Aspai Neumology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, SpainView further author information
, Arantzazu Alfrancaj Immunology Department, Instituto De Investigación Sanitaria La Princesa, Madrid, SpainView further author information
, Rebeca Mondejara Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, Spain;k Department of Medicine, Universidad Autónoma De Madrid, Madrid, SpainView further author information
& Ramon Colomera Medical Oncology Department, Instituto De Investigación Sanitaria La Princesa, HU La Princesa, Madrid, Spain;k Department of Medicine, Universidad Autónoma De Madrid, Madrid, SpainCorrespondence[email protected]
View further author information
show allView further author information
Article: 1751548
|
Received 16 Nov 2019, Accepted 29 Feb 2020, Published online: 16 Apr 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.